AN Adelaide-based pharmacist has been named one of Australia's "tall poppies of science" for her work with residents and carers in aged care to improve medicines safety among older people.
Dr Renly Lim (pictured), who is an NHMRC Early Career Fellow at UniSA's Quality Use of Medicines and Pharmacy Research Centre, is the clinical research leader of a trial evaluating a novel pharmacy service to prevent frailty and adverse events called ReMInDAR (Reducing medicine-induced deterioration and adverse reactions).
The Young Tall Poppy Science Awards, which were announced last week in a ceremony at the Adelaide Showgrounds, are an initiative of the Australian Institute of Policy and Science, aiming to recognise key achievements by Australia's finest scientists.
Dr Lim noted that about 250,000 hospital admissions each year are medicine-related, costing the nation $1.4 billion annually.
"My research looks at identifying the harms due to medicines and developing solutions to prevent these harms," she said.
Lim grew up in Malaysia and completed her pharmacy degree in Scotland and her PhD in Malaysia.
She's worked in the UK, Malaysia, Thailand and Cambodia, including organising workshops and drama performances in rural Cambodia to help increase the locals' understanding of malaria.
Dr Lim's current research interests include integrating digital health to improve medicine safety among older people, identifying associations between medicine use and health outcomes, health program evaluation and community engagement on malaria elimination.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Aug 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Aug 22